Apixaban ≥98%, solide cristallin
Marques : Cayman ChemicalTotal Evaluation: 0
Moyenne des Notes : 0.0 sur 5
|
Danger
|
Synonyme(s):
BMS56224701, 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[5,4-c]pyridine-3-carboxamide, 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
Apixaban is an orally bioavailable, selective inhibitor of both free and prothrombinase-bound factor Xa (Kis = 0.8 nM).
In vivo, apixaban has antithrombotic effects in a rabbit model of venous thrombosis. Apixaban (357.5 mg) also prevents thrombus formation without inducing adverse bleeding events in a porcine model of aortic heterotopic valve replacement. Formulations containing apixaban have been used to prevent blood clot formation in patients with atrial fibrillation.
Formule:
C₂₅H₂₅N₅O₄ Poids moléculaire: 459.5 g/mol Température de stockage: Congélateur |
Numéro MDL:
MFCD11977295 Numéro CAS: 503612-47-3 |
Résultats des tests de spécification
Purity | ≥98% |
λmax (UV/Vis) | 281 nm |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...